Bethlem muscular dystrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:610OMIM:620726G71.0
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bethlem muscular dystrophy (also known as Bethlem myopathy or early-onset benign autosomal dominant limb-girdle myopathy with contractures) is a relatively mild form of collagen VI-related muscular dystrophy. It is caused by mutations in the COL6A1, COL6A2, or COL6A3 genes, which encode the three alpha chains of type VI collagen — a key structural protein found in the extracellular matrix of skeletal muscle and connective tissues. The disease primarily affects the skeletal muscular system, leading to progressive proximal muscle weakness and characteristic joint contractures, particularly of the fingers (long finger flexors), wrists, elbows, and ankles. Onset is variable but often occurs in early childhood, though some individuals may not be diagnosed until adulthood. Affected individuals typically present with mild to moderate proximal limb weakness, hypotonia in infancy, and slowly progressive contractures of multiple joints. A distinctive feature is the combination of distal joint hyperlaxity (especially in the fingers and wrists during childhood) with proximal joint contractures. Skin findings such as follicular hyperkeratosis (rough, bumpy skin on the arms and legs), keloid formation, and soft, velvety skin on the palms and soles may also be present. Most patients remain ambulatory into adulthood, though some may require assistive devices later in life. Respiratory function can decline slowly over decades, and a subset of patients may eventually require nocturnal ventilatory support. There is currently no cure or disease-specific treatment for Bethlem muscular dystrophy. Management is supportive and multidisciplinary, including physical therapy to maintain joint mobility and muscle strength, orthopedic interventions for contractures, and monitoring of respiratory function. Genetic counseling is recommended for affected families. Research into collagen VI biology and potential therapeutic strategies, including gene therapy approaches, is ongoing.

Also known as:

Clinical phenotype terms— hover any for plain English:

Progressive proximal muscle weaknessHP:0009073Reduced muscle collagen VIHP:0030095Interphalangeal joint contracture of fingerHP:0001220Wrist flexion contractureHP:0001239Limb-girdle muscle weaknessHP:0003325Quadriceps muscle weaknessHP:0003731Ankle flexion contractureHP:0006466Increased muscle lipid contentHP:0009058Cigarette-paper scarsHP:0001073
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Bethlem muscular dystrophy.

View clinical trials →

No actively recruiting trials found for Bethlem muscular dystrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bethlem muscular dystrophy community →

Specialists

2 foundView all specialists →
CB
Christoffer R Vissing, BsC
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bethlem muscular dystrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bethlem muscular dystrophyForum →

No community posts yet. Be the first to share your experience with Bethlem muscular dystrophy.

Start the conversation →

Latest news about Bethlem muscular dystrophy

2 articles
NewsRSSApr 22, 2026
Exploring other mobility devices when a walker is no longer sufficient
A person with facioscapulohumeral muscular dystrophy (FSHD) is finding it harder to move around their home with a walker and is exploring other mobility options
AdvocacyRSSApr 22, 2026
Collaboration aims to improve design of FSHD clinical trials
Three organizations that work with facioscapulohumeral muscular dystrophy (FSHD) patients are joining together to make clinical trials better. FSHD is a rare mu
See all news about Bethlem muscular dystrophy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Bethlem muscular dystrophy

What is Bethlem muscular dystrophy?

Bethlem muscular dystrophy (also known as Bethlem myopathy or early-onset benign autosomal dominant limb-girdle myopathy with contractures) is a relatively mild form of collagen VI-related muscular dystrophy. It is caused by mutations in the COL6A1, COL6A2, or COL6A3 genes, which encode the three alpha chains of type VI collagen — a key structural protein found in the extracellular matrix of skeletal muscle and connective tissues. The disease primarily affects the skeletal muscular system, leading to progressive proximal muscle weakness and characteristic joint contractures, particularly of th

How is Bethlem muscular dystrophy inherited?

Bethlem muscular dystrophy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Bethlem muscular dystrophy?

2 specialists and care centers treating Bethlem muscular dystrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.